Results 31 to 40 of about 10,682,737 (276)

Combined Tumor Burden Score and Carbohydrate Antigen 19-9 Grading System to Predict Outcomes Among Patients with Intrahepatic Cholangiocarcinoma.

Journal of the American College of Surgeons, 2023
BACKGROUND The interplay of CA19-9 and tumor burden score (TBS) in intrahepatic cholangiocarcinoma (ICC) remains ill-defined. We evaluated the role of TBS and CA19-9 relative to overall survival (OS) and recurrence, as well as the predictive ability of ...
Z. Moazzam, L. Alaimo, Y. Endo, H. Lima, A. Ruzzenente, A. Guglielmi, L. Aldrighetti, M. Weiss, T. W. Bauer, S. Alexandrescu, G. Poultsides, S. Maithel, H. Marques, G. Martel, C. Pulitanò, F. Shen, F. Cauchy, B. Koerkamp, I. Endo, J. Cloyd, Aslam M. Ejaz, T. Pawlik   +21 more
semanticscholar   +1 more source

Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancer

International Journal of Biological Markers, 2022
Introduction Carbohydrate antigen 19-9 (CA19-9) is a well-studied tumor marker, yet its diagnostic value for gallbladder cancer remains unclear. The present meta-analysis was conducted to validate the role of serum CA19-9 for the detection of gallbladder
Xiaolei Zhou
semanticscholar   +1 more source

Carbohydrate antigen 19-9 electrochemical immunosensor based on 1D-MoS2 nanorods/LiNb3O8 and polyoxometalate-incorporated gold nanoparticles

, 2021
The diagnosis of disease and the monitoring of patient in cancer research are related to biomarkers. Carbohydrate antigen 19-9 (CA 19-9) as the main tumor biomarker is necessary for digestive tract associated cancers.
M. L. Yola, N. Atar
semanticscholar   +1 more source

Proposed carbohydrate antigen 19-9 (CA19-9) cut-off values for the detection of pancreatic cancer in patients with poorly controlled diabetes: a real-world study

Endocrine Journal, 2023
CA19-9 is a tumor marker for pancreatic cancer (PC), and the nondiabetic cut-off level is 37 U/mL. CA19-9 levels are said to rise in patients with tumors like PC and intraductal papillary mucinous neoplasm (IPMN). CA19-9 levels have also been shown to be
Taku Yamada, Taichi Minami, Masayo Yamada, Yasuo Terauchi   +3 more
doaj   +1 more source

CA 19-9 in Ovarian Immature Teratoma- A Potential Tumour Marker or A Masquerade? [PDF]

Journal of Clinical and Diagnostic Research, 2022
Carbohydrate antigen 19-9, also known as Cancer Antigen (CA 19-9) is a tumour marker found elevated in certain ovarian tumours. Although, reports of its association with mature teratoma are considerable, little is mentioned about its association with ...
Julie H John, R Sanghamita, Ajay Halder, Sramana Mukhopadhyay, Shweta Patel   +4 more
doaj   +1 more source

Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? [PDF]

, 2007
Background: The carbohydrate antigen 19-9 (CA 19-9) is currently the most widely used serum tumor marker in pancreatic cancer (PC). CA 19-9 pretreatment levels as well as CA 19-9 kinetics during systemic chemotherapy can provide prognostic information ...
Holdenrieder, Stefan, Weckbach, Sabine, Schulz, Christoph, Boeck, Stefan, Heinemann, Volker, Stieber, Petra   +5 more
core   +1 more source

Construction of a Label-Free Electrochemical Immunosensor Based on Zn-Co-S/Graphene Nanocomposites for Carbohydrate Antigen 19-9 Detection

Nanomaterials, 2021
Nanocomposites of the binary transition metal sulfide Zn-Co-S/graphene (Zn-Co-S@G) were synthesized through a one-step hydrothermal method. They may be useful in the construction of an electrochemical immunosensor for carbohydrate antigen 19-9 (CA19-9 ...
Chia-Wei Su, Jia-Hao Tian, Jin-Jia Ye, Han-Wei Chang, Yu-Chen Tsai   +4 more
semanticscholar   +1 more source

Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer

BJS Open, 2021
Background Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9 have been proposed as useful preoperative biomarkers of extrahepatic bile duct cancer (EBDC).
H. Kim, Youngmin Han, J. Kang, Yoon Hyung Kang, Mirang Lee, H. Sohn, Hongbeom Kim, W. Kwon, Jin-Young Jang   +8 more
semanticscholar   +1 more source

Table3_Preoperative Serum Carbohydrate Antigen 19-9 Levels Cannot Predict the Surgical Resectability of Pancreatic Cancer: A Meta-Analysis.pdf

, 2022
Background and Aims: Pancreatic ductal adenocarcinoma has one of the worst prognosis of all malignancies. This investigated the relationship between the preoperative serum carbohydrate antigen 19-9 and surgical resectability.Methods: A systematic search ...
Benedek Tinusz (7430090), Kata Szemes (6336017), Nelli Farkas (76461), Péter Hegyi (353118), Márton Benke (12520954), Bálint Erőss (6539930), Nóra Vörhendi (9438530), Ákos Szücs (3239229), Patrícia Sarlós (3308154), Zsolt Szakács (4568485)   +9 more
core   +1 more source

A One-Step Immunoassay for Carbohydrate Antigen 19-9 by Biosensor Based on Imaging Ellipsometry

, 2011
 Cancer markers can offer much more information for developing or developed cancers. Simple and short-time assay of cancer biomarker is essential for clinic diagnosis and management.
Huang CH (黄承洪), Jin G (靳刚), Chen YY (陈艳艳)   +2 more
core   +2 more sources